Joseph Heitman, M.D., Ph.D., James B. Duke Distinguished Professor and Chair, department of molecular genetics and microbiology, Duke University School of Medicine

Agata Smogorzewska, M.D., Ph.D., Skoler Horbach Family Professor and head, Laboratory of Genome Maintenance, The Rockefeller University

Bryan Dickinson, Ph.D., Professor, Department of Chemistry, The University of Chicago

Yun S. Song, Ph.D., professor of electrical engineering and computer sciences, statistics, director, center for computational biology, University of California, Berkeley

Lars F. Westblade, Ph.D., associate professor of pathology and laboratory medicine, Weill Cornell Medicine

Chongyi Chen, M.D., Ph.D., Stadtman Investigator, Laboratory of Biochemistry and Molecular Biology, National Cancer Institute, Center for Cancer Research

Sir Paul Nurse, Ph.D., President of the Royal Society, Chancellor of the University of Bristol, Chief Executive of Cancer Research UK

Rafal Piwowarczyk, graduate fellow, Klinge Lab, The Rockefeller University

Hannah Haberkern, Ph.D., Emmy Noether group leader and chair of behavioral physiology and sociobiology, University of Würzberg, Germany

Pulin Li, Ph.D., assistant professor, Whitehead Institute at Massachusetts Institute of Technology

Willliam Kaelin, M.D., Sidney Farber Professor of Medicine, Dana-Farber Cancer Institute; Harvard Medical School; investigator, Howard Hughes Medical Institute

Mary E. Hatten, Ph.D., Frederick P. Rose Professor and head, Laboratory of Developmental Neurobiology, The Rockefeller University

Arseny Finkelstein, Ph.D., assistant professor, Tel Aviv University

John Watters, graduate fellow, Liu Lab, The Rockefeller University

Shai Shaham, Ph.D., Richard E. Salomon Family Professor and Head of the Laboratory of Developmental Genetics, The Rockefeller University

Xiaowei Zhuang, Ph.D., David B. Arnold Jr. Professor of Science, professor of chemistry and chemical biology, professor of physics, Harvard University; investigator, Howard Hughes Medical Institute

Erika Pearce, Ph.D., scientific director, BKI Institute for Cancer Immunotherapy Molecular Biology; professor of oncology, biochemistry and molecular biology, Johns Hopkins University School of Medicine

9:00 a.m.: Shane Krska, Ph.D., discovery chemistry, Merck, Accelerating Drug Discovery Through Innovations in Catalysis and Industry-Academic Partnerships

9:20 a.m.: Martin Tomanik, Ph.D., assistant professor, department of chemistry, New York University, Radical-Triggered Functional Group Translocation and Total Synthesis of Talaromyolide D

9:40 a.m.: Danielle Schultz, Ph.D., process chemistry, Merck, Harnessing Collaboration and Enabling Technologies to Move Fast and Break Boundaries in Drug Discovery

10:00 a.m.: Jiankun Lyu, Ph.D., assistant professor and head of lab, The Rockefeller University, Virtual Screening of 100+-Billion-Molecule Libraries for Prospective Ligand Discovery

10:45 a.m.: Daniel Keedy, Ph.D., associate professor, City University of New York, High-Throughput Mapping of Ligandability in Allosteric Enzymes by Crystallographic Fragment Screening

11:05 a.m.: Yacob Gomez Llorente, Ph.D., and Sandra Gabelli, Ph.D, structural chemistry, Merck, Driving Pharmaceutical Breakthroughs through Structural Biology: Enlicitide a case study

11:25 a.m.: Chi-Min (Mimi) Ho, Ph.D., assistant professor, department of microbiology and immunology, Columbia University, Molecular Basis of Malarial Host-Cell Invasion

11:45 a.m.: Kaavya Krishna Kumar, Ph.D., assistant professor of pharmacology, Weill Cornell Medicine, Design of Safer Cannabinoid Receptor Ligands

12:05 p.m.: Michael Lazarus, Ph.D., associate professor of pharmacological sciences, the Icahn School of Medicine at Mount Sinai, Structural and Biochemical Studies on the Enigmatic YicC Family of RNases

2:00 p.m.: Heeseon An, Ph.D., assistant member, chemical biology program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase1 Inhibitors for Targeting Mevalonate Metabolism in Cancer

2:20 p.m.; Christine Iok In Chio, Ph.D., assistant professor of genetics and development, Institute for Cancer Genetics, Columbia University Irving Medical Center, Redox Control of Systemic Metabolism in Cancer and Metabolic Disease

2:40 p.m.: Ralph Kleiner, Ph.D., associate professor of chemistry, Princeton University, Illuminating RNA Biology with Metabolically Incorporated Ribonucleoside Probes

3:00 p.m.: Jennifer Hickey, Ph.D., discovery chemistry, Merck, Oral Macrocyclic Peptide Inhibitors of IL-1β

David M. Altshuler, M.D., Ph.D., executive vice president; chief scientific officer, Vertex Pharmaceuticals

Hari Shroff, Ph.D., senior investigator, molecular tools and imaging, Howard Hughes Medical Institute

Zehao Zhang, graduate fellow, Cao Lab, The Rockefeller University

Don Cleveland, Ph.D., chair, department of cellular and molecular medicine, University of California at San Diego; head, laboratory for cell biology, Ludwig Cancer Research

Charles Swanton, Ph.D., FRCP, deputy clinical director, The Francis Crick Institute

Peter Schade, graduate fellow, Freiwald and Jarvis Labs, The Rockefeller University

Nihal Altan-Bonnet, Ph.D., Senior Investigator and Head, Laboratory of Host Pathogen Dynamics, National Heart, Lung, and Blood Institute, National Institutes of Health

Celina Juliano, Ph.D., associate professor, department of molecular and cellular biology, University of California, Davis, Nervous System Maintenance and Regeneration in Hydra

Elly Tanaka, scientific director, Institute of Molecular Biotechnology, Stem Cells to Behavior: CNS Regeneration in a Tetrapod Nervous System

Tomohisa Toda, Ph.D., professor, FAU Erlangen, Exploring the Role of Long-lived Molecules in Brain Maintenance and Plasticity

Claudia Kawas, M.D., professor of neurology, professor of neurobiology and behavior, University of California, Irvine, Old Brains, New Insights: The 90+ Study

Edward Tate, Ph.D., GSK Chair in Chemical Biology, Imperial College London & The Francis Crick Institute, Targeting Post-Translational Modification in Cancer

Cigall Kadoch, Ph.D., professor and Meredith and Billy Starr Investigator, department of pediatric oncology, Dana-Farber Cancer Institute and Harvard Medical School; institute member and epigenomics program co-director, Broad Institute of MIT and Harvard; investigator, Howard Hughes Medical Institute

Brian Brown, Ph.D., director, Icahn Genomics Institute, Mount Sinai Medical Center, Pancreatic Cancer Control of Immune Neighborhoods

Dietmar Zehn, Ph.D., professor, executive director at the TUM Center for Infection Prevention, Technical University Munich

Michael Yale, M.D., Ph.D., David H. Koch Professor of Science, Massachusetts Institute of Technology, Kinase Signaling and DNA Repair Choice in Cancer and Neurodegenerative Diseases

Greg Thurber, Ph.D., professor, University of Michigan, Incorporating Molecular Design into Antibody Drug Conjugates and Other Targeted Therapeutics

Yogesh Goyal, Ph.D., investigator, Chan Zuckerberg Biohub and assistant professor, Northwestern University